List/Grid
Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
– Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD–19 x FcγRIIb inhibitor of B cell function–
–Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis... More >>
ياندكس تطور وتفتح المصادر Perforator، أداة مفتوحة المصدر يمكنها توفير مليارات الدولارات للشركات سنويًا على البنية التحتية للخادم
- تقدم Yandex أداة Perforator، وهي أداة... More >>
Yandex desenvolve e abre códigos Perforator, uma ferramenta de código aberto que pode economizar bilhões de dólares por ano para as empresas em infraestrutura de servidores
- Yandex apresenta o Perforator, uma ferramenta que pode identificar e avaliar ineficiências de código em toda a base de código de uma empresa.
- O Perforator ajuda os desenvolvedores a identificar as seções de... More >>
Yandex développe et open-source Perforator, un outil open source qui peut permettre aux entreprises d'économiser des milliards de dollars par an sur l'infrastructure de serveur
- Yandex présente Perforator, un outil capable d'identifier et d'évaluer les inefficacités du code dans l'ensemble de la base de code d'une entreprise.
- Perforator aide les développeurs à... More >>
Lantronix stellt auf der Cisco Live erstmals die neue LM4-Out-of-Band-Management-Plattform mit KI-Unterstützung vor
IRVINE, Kalifornien, Feb. 05, 2025 (GLOBE NEWSWIRE) —
Lantronix Lança LM4, Nova Plataforma Out-of-Band Management Alimentada por IA na Cisco Live
IRVINE, Califórnia, Feb. 05, 2025 (GLOBE NEWSWIRE) — A
Digital 2025: AI accelerates, YouTube tops user charts, social ad spend soars and more
SAN FRANCISCO, Feb. 05, 2025 (GLOBE NEWSWIRE) —